Published in Yale J Biol Med on June 01, 1962
Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev (2004) 3.40
Relation of mucoid growth of Staphylococcus aureus to clumping factor reaction, morphology in serum-soft agar, and virulence. J Bacteriol (1968) 3.01
Biological and Immunological Properties of Encapsulated Strains of Staphylococcus aureus from Human Sources. Infect Immun (1970) 2.68
Biological properties of the encapsulated Staphylococcus aureus M. Infect Immun (1974) 2.58
Phenotypic variation of Staphylococcus epidermidis slime production in vitro and in vivo. Infect Immun (1987) 2.29
A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. Infect Immun (1996) 2.13
Virulent and avirulent encapsulated variants of Staphyococcus aureus. J Bacteriol (1968) 1.96
Factors relating to the virulence of Staphylococci. II. Observations on four mouse-pathogenic strains. J Exp Med (1962) 1.93
Effects of in vitro and in vivo growth conditions on expression of type 8 capsular polysaccharide by Staphylococcus aureus. Infect Immun (1993) 1.90
Pseudocompact-type growth and conversion of growth types of strains of Staphylococcus aureus in vitro and in vivo. J Bacteriol (1969) 1.81
Comparison of Compact and Diffuse Variants of Strains of Staphylococcus aureus. Infect Immun (1970) 1.81
Observations on the immunology of pathogenic staphylococci. Yale J Biol Med (1962) 1.76
Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies. Yale J Biol Med (1967) 1.75
Phagocytic killing of encapsulated and microencapsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Infect Immun (1992) 1.67
Factors relating to the virulence of Staphylococci. III. Antibacterial versus antioxic immunity. J Exp Med (1962) 1.53
Nature of the genetic determinant controlling encapsulation in Staphylococcus aureus Smith. Infect Immun (1977) 1.35
Clumping of Staphylococcus aureus in the peritoneal cavity of mice. J Bacteriol (1966) 1.30
STUDIES OF STAPHYLOCOCCAL INFECTIONS. I. VIRULENCE OF STAPHYLOCOCCI AND CHARACTERISTICS OF INFECTIONS IN EMBRYONATED EGGS. J Clin Invest (1964) 1.26
Lysostaphin: an enzymatic approach to staphylococcal disease. II. In vivo studies. Yale J Biol Med (1967) 1.23
Abscess formation and alpha-hemolysin induced toxicity in a mouse model of Staphylococcus aureus peritoneal infection. Infect Immun (2012) 1.16
Isolation of Staphylococcus aureus clumping factor. Infect Immun (1985) 1.14
Encapsulated, coagulase-negative strain of Staphylococcus simulans. Infect Immun (1981) 0.94
Antiserum agar method for identification of Smith type exopolysaccharides in clinical isolates of Staphylococcus aureus. J Clin Microbiol (1985) 0.91
Detection of encapsulation in Staphylococcus aureus by use of antiserum agar. J Clin Microbiol (1984) 0.91
Compact-type growth of Staphylococcus epidermidis strains in serum-soft agar. Infect Immun (1971) 0.85
Chemotaxigenesis by encapsulated Staphylococcus aureus M. Infect Immun (1980) 0.84
ABSORPTION OF THE ANTIBACTERIAL SERUM FACTOR BY STAPHYLOCOCCI. J Bacteriol (1963) 0.81
Possible common biological and immunological properties for detecting encapsulated strains of Staphylococcus epidermidis. J Clin Microbiol (1988) 0.79
Effect of tilorone on susceptibility of mice to primary or secondary infection with Listeria monocytogenes. Infect Immun (1976) 0.79
Studies of staphylococcal infections. II. The role of bacteriophage type, antibiotic resistance, coagulase, and other exotoxins in infections in embryonated eggs. Yale J Biol Med (1966) 0.78
Pseudodiffuse-type growth of a Staphylococcus aureus strain in serum-soft agar. J Clin Microbiol (1985) 0.75
Serum factors and the reticuloendothelial uptake of Staphylococcus aureus. II. Role of a zymosan-adsorbable serum opsonin. Infect Immun (1971) 0.75
Interactions between rabbit polymorphonuclear leucocytes and staphylococci. J Exp Med (1959) 17.17
The behavior of virulent and avirulent staphylococci in the tissues of normal mice. J Exp Med (1956) 6.31
The bacteriophage typing of staphylococci. J Infect Dis (1953) 4.94
Characteristics of coagulase positive and coagulase negative staphylococci in serum-soft agar. J Bacteriol (1958) 4.63
Acute infection of mice with Smith strain of Staphylococcus aureus. Science (1958) 4.28
STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : I. THE ACTION OF TYPE SPECIFIC ANTIBODY UPON THE PULMONARY LESION OF EXPERIMENTAL PNEUMONIA. J Exp Med (1941) 4.10
The enhancement of infection during shock produced by bacterial toxins and other agents. Br J Exp Pathol (1950) 3.90
Studies on bacteriemia. I. Mechanisms relating to the persistence of bacteriemia in rabbits following the intravenous injection of staphylococci. J Exp Med (1956) 3.21
Further observations on the behavior of staphylococci within human leukocytes. J Exp Med (1960) 2.89
Pathogenic staphylococci; detection of alpha-lysin production on rabbit- and sheep-blood-agar plates. Br Med J (1948) 2.85
The nature of discrepancies between haemolysins in culture filtrates and plate haemolysin patterns of staphylococci. J Pathol Bacteriol (1954) 2.80
Opsonins as determinants of survival in intraperitoneal infections of mice. Nature (1959) 2.74
A mucoid form of Micrococcus pyogenes var aureus which shows capsular swelling with specific immune serum. J Bacteriol (1954) 2.43
Isolation of a phagocytosis-inhibiting substance from culture filtrates of an encapsulated Staphylococcus aureus. Nature (1960) 2.41
The influence of the route of injection on lethal infections in mice. Br J Exp Pathol (1955) 2.25
The development of the acute inflammatory response to experimental cutaneous mucormycosis in normal and diabetic rabbits. J Exp Med (1959) 2.23
The effect of antimicrobial drugs on an experimental staphylococcal infection in mice. Ann N Y Acad Sci (1956) 2.21
Further studies of the phenomenon of capsular swelling of Micrococcus pyogenes var. aureus in the presence of immune serum. J Bacteriol (1956) 2.19
Pathogenicity of staphylococci; a comparison of alpha-hemolysin production with the coagulase test and clinical observations of virulence. N Engl J Med (1955) 2.14
Dissociation in an Encapsulated Staphylococcus. J Bacteriol (1931) 2.02
Studies on staphylococci. I. Effect of serum and coagulase on the metabolism of coagulase positive and coagulase negative strains. J Bacteriol (1959) 2.00
Variation in the antigenic composition of staphylococcal coagulase. J Gen Microbiol (1952) 1.86
Observations on the immunology of pathogenic staphylococci. Yale J Biol Med (1962) 1.76
Fate of staphylococci within human leukocytes. J Exp Med (1960) 1.55
Pathogenic Staphylococci in the Nose. Br Med J (1938) 1.47
Studies on bacteriemia. V. The effect of simultaneous leukopenia and reticuloendothelial blockade on the early blood stream clearance of staphylococci and Escherichia coli. J Exp Med (1961) 1.20
Inhibition of neutrophil mobilization by colchicine. Proc Soc Exp Biol Med (1960) 0.97
Factors relating to the virulence of Staphylococci. II. Observations on four mouse-pathogenic strains. J Exp Med (1962) 1.93
Factors relating to the virulence of Staphylococci. III. Antibacterial versus antioxic immunity. J Exp Med (1962) 1.53
Enterococcal endocarditis. Report of nineteen cases with long-term follow-up data. N Engl J Med (1961) 1.41
THE DYNAMICS OF RETICULOENDOTHELIAL BLOCKADE. J Exp Med (1965) 1.36
CLINICAL AND LABORATORY OBSERVATIONS ON TYPE E BOTULISM IN MAN. Medicine (Baltimore) (1964) 1.19
Oral treatment of subacute bacterial endocarditis with phenoxymethyl penicillin (penicillin V). N Engl J Med (1957) 0.93
Current status of therapy in acute osteomyelitis. JAMA (1962) 0.85
The action of certain antibiotics and antibiotic combinations against Proteus mirabilis with demonstration of in vitro synergism and antagonism. Am J Med Sci (1961) 0.80
STUDIES ON EXPERIMENTAL BACTEREMIA AND RETICULOENDOTHELIAL FUNCTION. Trans Am Clin Climatol Assoc (1964) 0.79
THE TREATMENT OF STAPHYLOCOCCAL INFECTIONS. Med Clin North Am (1963) 0.75
An approach to the antimicrobial therapy of common infections. Am Pract Dig Treat (1962) 0.75
CLINICAL AND LABORATORY MANIFESTATIONS OF TYPE E BOTULISM IN MAN. Trans Assoc Am Physicians (1964) 0.75